Eugenio Brunocilla

Medicine & Life Sciences

1. fluciclovine F-18 100%
2. Pandemics 80%
3. Urinary Bladder Neoplasms 63%
4. Nephrectomy 53%
5. Choline 51%
6. Prostatic Neoplasms 51%
7. Robotics 48%
8. SARS Virus 47%
9. Nomograms 46%
10. Urology 38%
11. Cohort Studies 38%
12. Cystectomy 36%
13. Area Under Curve 32%
14. Multicenter Studies 29%
15. Registries 27%
16. Acute Kidney Injury 25%
17. Lymph Nodes 22%
18. Disease Outbreaks 22%
19. Internship and Residency 22%
20. Neoplasm Metastasis 19%
21. Laparoscopy 19%
22. Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC)) 19%
23. Health Status 18%
24. Prostate 17%
25. Lymph Node Excision 16%
26. Kidney 16%
27. Ischemia 16%
28. Nephroureterectomy 14%
29. Prostatectomy 13%
30. Outpatients 12%
31. Solid-State Lasers 11%
32. Learning 11%
33. Renal Cell Carcinoma 10%
34. Recurrence 10%
35. Mycobacterium bovis 10%
36. Neoplasms 9%
37. Time-to-Treatment 9%
38. Hospital Restructuring 9%
39. Therapeutics 9%
40. Bone Marrow 9%
41. Prospective Studies 9%
42. Neoplasm Staging 9%
43. Glomerular Filtration Rate 9%
44. Postoperative Complications 8%
45. Odds Ratio 8%
46. Disease Management 8%
47. Italy 8%
48. Distance Education 7%
49. Social Distance 7%
50. Life Expectancy 7%